Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AVPR1A | P37288 | 1/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 11/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 7/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 8/20 | 0.47 |
| ▸ | USP2 | O75604 | 5/20 | 0.47 |
| ▸ | TSHR | P16473 | 5/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 9/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 5/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 5/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6155641 | 0.87 | AVPR1A (0.52) | AVPR1AMEN1KMT2ATSHRALDH1A1 | |
| SCHEMBL6155331 | 0.86 | AVPR1A (0.48) | AVPR1AMAPK1TSHRALOX15 | |
| SCHEMBL6153716 | 0.82 | KDM1A (0.50) | AVPR1ACYP2C19MEN1KMT2A | |
| SCHEMBL9965972 | 0.81 | AVPR1A (0.48) | AVPR1AMAPK1TSHR | |
| SCHEMBL6154922 | 0.79 | AVPR1A (0.51) | AVPR1ACYP3A4CYP2C19MAPK1TSHR | |
| SCHEMBL9963297 | 0.75 | AVPR1A (0.44) | AVPR1ACYP2D6ALDH1A1 | |
| SCHEMBL6155345 | 0.72 | CYP3A4 (0.49) | CYP3A4CYP2C19MAPK1MEN1KMT2A | |
| SCHEMBL6097273 | 0.70 | NOTUM (0.58) | CYP3A4CYP2C19MAPK1MEN1KMT2A | |
| SCHEMBL762556 | 0.69 | AVPR1A (0.43) | AVPR1ATSHR | |
| Hydrochloric Acid SCHEMBL7500487 | 0.68 | AVPR1A (0.42) | AVPR1ATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050209262-A1 | Process for producing optically active sulfoxide | SANKYO COMPANY, LIMITED (JP) | 2005-09-22 | — | — | US | disclosed |
| EP-1557420-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE SULFOXIDE | Sankyo Company, Limited (JP) | 2005-07-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050209262-A1 | Process for producing optically active sulfoxide | TST, TMT1A, PPOX | AVPR1A 3530/4885CYP3A4 185/4885CYP2C19 967/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.